MAPT and Alzheimer disease: The three core findings of the largest prospective longitudinal ADNI study thus far were as follows1: Aβ‐PET and CSF tau pathology were related to the cognitive decline across the AD clinical spectrum, both as potential predictors for dementia progression.2